Hisae Niki, MSc

Mitsubishi Tanabe Pharma Corporation
Aoba-ku, Yokohama, Kanagawa, Japan

a senior research scientist

Presentation(s):

• 0052: Profiling of MT-3534, a Humanized Monoclonal Antibody Targeting Peptidylarginine Deiminase 4, as a Candidate Drug for the Treatment of RA

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Mitsubishi Tanabe Pharma Corporation: Employee (Ongoing)